Department of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.
BMC Pregnancy Childbirth. 2024 Feb 2;24(1):104. doi: 10.1186/s12884-024-06296-3.
Excessive gestational weight gain, especially among women with gestational diabetes, is associated with several adverse perinatal outcomes. Our study aimed to analyse the impact of the use of pedometers to supervise physical activity on maternal health and the obstetric outcomes of pregnant women with obesity and early gestational diabetes.
124 pregnant patients were enrolled in the presented research.
singleton pregnancy, age > 18 years, gestational diabetes diagnosed in the first half of pregnancy (< 20th week of pregnancy), obesity according to the American Endocrine Society criteria. Each patient was advised to take at least 5000 steps daily. Patients were randomly assigned to pedometers (N = 62), and were recommended to monitor daily the number of steps. The group without pedometers (N = 62) was not observed. Visit (V1) was scheduled between the 28th and 32nd gestational week (GW), and visit (V2) occurred between the 37th and 39th GW. Anthropometric measurements and blood samples were collected from all patients at each appointment. Foetal and maternal outcomes were analysed at the end of the study.
In the group supervised by pedometers, there were significantly fewer newborns with macrosomia (p = 0,03). Only 45% of patients satisfied the recommended physical activity guidelines. Patients who walked more than 5000 steps per day had significantly higher body weight at baseline (p = 0,005), but weight gain was significantly lower than in the group that did not exceed 5000 steps per day (p < 0,001). The perinatal outcome in the group of patients performing more than 5000 steps did not demonstrate significant differences with when compared to less active group. ROC curve for weight gain above the guidelines indicated a statistically substantial cut-off point for this group at the level of 4210 steps/day (p = 0.00001).
Monitoring the activity of pregnant patients with gestational diabetes and obesity by pedometers did not have a significantly impact on their metabolic control and weight gain. However, it contributed to less macrosomia. Furthermore, physical activity over 5,000 steps per day positively affects weight loss, as well as contributes to improved obstetric and neonatal outcomes.
过度的妊娠体重增加,尤其是在患有妊娠糖尿病的女性中,与多种围产期不良结局相关。本研究旨在分析使用计步器来监测体力活动对肥胖和早期妊娠糖尿病孕妇的产妇健康和产科结局的影响。
本研究纳入了 124 名孕妇。
单胎妊娠、年龄>18 岁、妊娠糖尿病在妊娠早期(<20 孕周)诊断、根据美国内分泌学会标准诊断肥胖。每位患者均被建议每天至少行走 5000 步。患者被随机分配至计步器组(N=62),并被建议每天监测步数。无计步器组(N=62)则不进行观察。就诊(V1)安排在妊娠 28-32 周之间,就诊(V2)安排在妊娠 37-39 周之间。每次就诊时,所有患者均采集体格测量和血样。在研究结束时分析胎儿和产妇结局。
在计步器组中,新生儿巨大儿的比例显著降低(p=0.03)。仅 45%的患者满足推荐的体力活动指南。每天行走超过 5000 步的患者在基线时体重显著更高(p=0.005),但体重增加显著低于每天行走不足 5000 步的患者(p<0.001)。每天行走超过 5000 步的患者的围产期结局与活动较少的患者相比无显著差异。体重增加超过指南的 ROC 曲线表明,该组的统计学显著截止点为每天 4210 步(p=0.00001)。
通过计步器监测患有妊娠糖尿病和肥胖的孕妇的活动并没有显著影响其代谢控制和体重增加。然而,它有助于减少巨大儿的发生。此外,每天进行 5000 步以上的体力活动对减轻体重有积极影响,并有助于改善产科和新生儿结局。